Dear Editor,We read with great interest the article reporting the results of the CONFIDent trial which aimed to assess the short-term efficacy of PTNS against sham electrical stimulation in adults with faecal incontinence (FI). 1 The authors should certainly be congratulated for completing the study since surgical trials are notoriously difficult to implement but we would like to comment on its conclusions in view of our great experience administrating the therapy and treating such patients. 2,3 The authors conclude that PTNS did not confer any significant clinical benefit after 12 weeks because the primary outcome (i.e. 50% reduction in weekly incontinence episodes) was not found to be statistically different between PTNS (38% achieved the primary outcome) and sham (31%) patients. Firstly, it is debatable whether the selection of this outcome is an appropriate metric to quantify symptom improvements particularly after a very short period of three months when patients had symptoms for 48-60 months. We do wonder whether physicians in other specialties would render a treatment ineffective if a 50% reduction, in cholesterol levels for example, was not achieved within a few weeks. Interestingly, the 25%, 75% and 100% reduction in incontinence episodes all showed a trend favouring PTNS, albeit not statistically significant. Despite the (in)appropriateness of the chosen primary outcome, it is can